PUBLISHER: BCC Research | PRODUCT CODE: 1847094
PUBLISHER: BCC Research | PRODUCT CODE: 1847094
The global market for fusion proteins is expected to grow from $36.3 billion in 2025 to reach $64.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.3% from 2025 to 2030.
The North American market for fusion proteins is expected to grow from $13.3 billion in 2025 to reach $22.9 billion by the end of 2030, at a CAGR of 11.6% from 2025 to 2030.
The Asia-Pacific market for fusion proteins is expected to grow from $9 billion in 2025 to reach $17.6 billion by the end of 2030, at a CAGR of 14.5% from 2025 to 2030.
The report provides an overview of the global fusion proteins market and analyzes market trends. It includes global revenue ($ million) for the base year 2024, estimated data for 2025 and forecast data from 2026 through 2030. The market is segmented based on type, route of administration, application and region.
According to type, the market is segmented into cytokine traps, peptide-based fusion proteins, receptor-based fusion proteins and others. Based on application, the market is segmented into ophthalmic conditions, autoimmune diseases, metabolic disorders and hematological diseases. Regarding the route of administration, the market is segmented into intravenous, subcutaneous, intravitreal and others. The report also focuses on regional segmentation, including North America, Europe, Asia-Pacific and the Rest of the World, focusing on major countries in these regions.
The report focuses on the major driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and corporate governance developments and discusses pipeline activities and emerging technologies related to the market. The report concludes with an analysis of the competitive landscape and industry structure. It also includes a dedicated section featuring company profiles with detailed information about leading companies. The scope of the report focuses on Fc-fusion protein products.